A Prospective Study on Effect of Low Dose Mifepristone in Uterine Leiomyoma
Journal Title: Indian Journal of Obstetrics and Gynecology - Year 2019, Vol 7, Issue 2
Abstract
Context: Uterine leiomyomas is the most common benign tumor of the uterus and one of the most frequent indications for operative procedures. High dose of mifepristone used to treat leiomyomas have resulted in side effects. Hence this study was done to evaluate effects of low dose mifepristone. Aims: To evaluate the effectiveness of low dose Mifepristone in the treatment of Uterine Leiomyoma. Settings and Design: A prospective observational study was conducted among 60 women diagnosed with uterine leiomyoma in a tertiary hospital at Karaikal. Methods and Material: Data was collected using standardized questionnaire. Blood investigation and ultrasound pelvis was done to evaluate the effects on uterine leiomyoma before and after treatment with 10 mg of mifepristone for three months. Statistical analysis used: Mean and standard deviations were used to present quantitative data. Association was tested using Chi square, McNemar test, Paired t test and Wilcoxin test. Results: Maximum participants were between 40-49 years. More than half of the study participants were relieved of dysmenorrhea after the treatment. The Mean PBAC values reduced from 124.6 ± 51.85 to 34.72 ± 17.87 which was highly significant. There was significant reduction in the uterine volume from 331.69 ± 216.05 to 239.68 ± 157.23 cm3 and the Leiomyoma volume from 68.62 ± 38.94 to 46.71 ± 27.96 cm3. About 78% of the study population experienced amenorrhea after the therapy. Conclusions: Low dose of Mifepristone was effective in reducing the size of uterine leiomyoma and also decreasing symptoms of dysmenorrhoea and menorrhagia thus improving the general health status and quality of life of the study population.
Authors and Affiliations
Geetha Krishnamoorthy
Keywords
Related Articles
- EP ID EP627431
- DOI 10.21088/ijog.2321.1636.7219.30
- Views 93
- Downloads 0
A Clinicopathological Study of Endometriosis with Special Reference to Endometriosis in Very Rare Locations
Endometriosis is a chronic debilitating disease that occurs in 6-10% of the female population and about 35-50% of women with pain, infertility or both and characterized by endometrial tissue outside the uterine cavity. E...
Evaluation of Coagulation Disturbances in Patients with Polycystic Ovary Syndrome
Background: Polycystic ovarian syndrome (PCOS) patients are prone to develop insulin resistance with compensatory hyperinsulinemia, dyslipidemia, hypertension, and obesity. There is evidence that plasma levels of several...
A Study of Relationship Between Second Trimester Maternal Serum Beta Human Chorionic Gonadotropin and Hypertensive Disorder of Pregnancy
Objective: To test the hypothesis that women with high serum beta HCG levels in early second trimester (13-20 weeks) are at higher risk of developing hypertensive disorder of pregnancy and to compare beta HCG levels betw...
A Study to Compare the Maternal and Fetal Outcome in Term Singleton Pregnancies Having AFI < 8CM to those having AFI 8.1-20 CM.
Background and Purpose: Over many decades, studies have been conducted in various parts of the world in an attempt to correlate the AFI with fetal and maternal outcome. Recent studies, however, have challenged the relati...
Awareness on Complications of Fever in Early Pregnancy
Background: Fever is the most common way of presenting any type of infections, which when left without appropriate treatment can result in adverse foetal as well as maternal outcomes. Fever can easily be presented during...